Aura Biosciences annual r&d spending
2020
2021
2022
2023
2024
2025
Aura Biosciences R&D Spending Growth & History (AURA)
Aura Biosciences's r&d spending was $90.3M for fiscal 2025.
View full Aura Biosciences company overviewAura Biosciences annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $90.3M | $17.0M | +23.19% |
| 2024 | 2024-12-31 | $73.3M | $8.1M | +12.37% |
| 2023 | 2023-12-31 | $65.2M | $23.0M | +54.44% |
| 2022 | 2022-12-31 | $42.2M | $17.1M | +67.87% |
| 2021 | 2021-12-31 | $25.2M | $7.1M | +39.46% |
| 2020 | 2020-12-31 | $18.0M | — | — |
Aura Biosciences quarterly r&d spending
Q3.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | R&D spending | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $30.7M | $7.9M | +34.38% |
| Q1 2026 | 2026-03-31 | $28.0M | $4.6M | +19.78% |
| Q4 2025 | 2025-12-31 | $21.9M | −$438,000 | −1.96% |
| Q3 2025 | 2025-09-30 | $22.2M | $5.1M | +30.18% |
| Q2 2025 | 2025-06-30 | $22.9M | $6.0M | +35.56% |
| Q1 2025 | 2025-03-31 | $23.3M | $6.3M | +36.89% |
| Q4 2024 | 2024-12-31 | $22.3M | $2.1M | +10.14% |
| Q3 2024 | 2024-09-30 | $17.0M | $1.6M | +10.42% |
| Q2 2024 | 2024-06-30 | $16.9M | $1.8M | +11.63% |
| Q1 2024 | 2024-03-31 | $17.1M | $2.6M | +18.38% |
| Q4 2023 | 2023-12-31 | $20.3M | $7.1M | +54.11% |
| Q3 2023 | 2023-09-30 | $15.4M | $4.1M | +36.62% |
| Q2 2023 | 2023-06-30 | $15.1M | $5.6M | +58.99% |
| Q1 2023 | 2023-03-31 | $14.4M | $6.1M | +74.06% |
| Q4 2022 | 2022-12-31 | $13.2M | $5.2M | +64.92% |
| Q3 2022 | 2022-09-30 | $11.3M | $4.9M | +77.42% |
| Q2 2022 | 2022-06-30 | $9.5M | $2.9M | +43.40% |
| Q1 2022 | 2022-03-31 | $8.3M | $4.1M | +97.75% |
| Q4 2021 | 2021-12-31 | $8.0M | — | — |
| Q3 2021 | 2021-09-30 | $6.4M | $3.5M | +123.33% |
| Q2 2021 | 2021-06-30 | $6.6M | — | — |
| Q1 2021 | 2021-03-31 | $4.2M | — | — |
| Q3 2020 | 2020-09-30 | $2.9M | — | — |
Aura Biosciences r&d spending trends
Over the last five fiscal years, Aura Biosciences's r&d spending increased from $18.0M to $90.3M, a change of $72.3M. The latest reported quarter, Q2 2026, shows $30.7M.
About the metric
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
Calculation and source
SEC-reported R&D expense
TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Aura Biosciences source filings ↗